Categories
Tags
Authors: Verma AK, Lavine KJ, Lin CY PMID: 34407340 PMCID: PMC8385564 DOI: 10.1056/NEJMc2109975 Abstract The Centers for Disease Control and Prevention recently reported cases of myocarditis and pericarditis in the United States after coronavirus disease 2019 (Covid-19) messenger RNA (mRNA) vaccination.1 In recently published reports, diagnosis of myocarditis was made with the use of noninvasive [...]
Categories: I-RECOVER Post-Vaccine
Authors: Hekimian G, Kerneis M, Zeitouni M, Cohen-Aubart F, Chommeloux J PMID: 32910974 PMCID: PMC7476896 DOI: 10.1016/j.chest.2020.08.2099 Abstract Hyperinflammatory shock was described recently in children during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. The clinical presentation of these patients involved fever, cutaneous rash, abdominal symptoms, distributive shock, and acute cardiac injury. This multisystem [...]
Categories: MATH+
Tags: COVID-19, Myocarditis
Authors: Ma KL, Liu ZH, Cao CF, Liu MK, Liao J doi: https://doi.org/10.1101/2020.03.19.20034124 Abstract Background Notwithstanding the clinical hallmarks of COVID-19 patients were reported, several critical issues still remain mysterious, i.e., prognostic factors for COVID-19 including extrinsic factors as viral load of SARS-CoV-2 and intrinsic factors as individual’s health conditions; myocarditis [...]
Categories: MATH+
Tags: COVID-19, Myocarditis
Authors: Wang YH, Li SA, Huang CH, Su HH, Chen YH PMID: 29962953 PMCID: PMC6013847 DOI: 10.3389/fphar.2018.00636 Abstract Lumbrokinase is used as an oral supplement to support and maintain healthy cardiovascular function, and to treat cardiovascular diseases in clinical for more than 10 years. Up until now, the mechanism of the cardioprotective effects of post-ischemic [...]
Categories: I-RECOVER Post-Vaccine
Tags: Lumbrokinase, Myocarditis